featured
Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents vs Thin, Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularisation (BIOFLOW V): A Randomised Trial
Lancet 2017 Aug 25;[EPub Ahead of Print], DE Kandzari, L Mauri, JJ Koolen, JM Massaro, G Doros, HM Garcia-Garcia, J Bennett, A Roguin, EG Gharib, DE Cutlip, R WaksmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.